Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases
Ali Bodaghi,
No information about this author
Nadia Fattahi,
No information about this author
Ali Ramazani
No information about this author
et al.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(2), P. e13323 - e13323
Published: Jan. 30, 2023
The
use
of
biomarkers
as
early
warning
systems
in
the
evaluation
disease
risk
has
increased
markedly
last
decade.
Biomarkers
are
indicators
typical
biological
processes,
pathogenic
or
pharmacological
reactions
to
therapy.
application
and
identification
medical
clinical
fields
have
an
enormous
impact
on
society.
In
this
review,
we
discuss
history,
various
definitions,
classifications,
characteristics,
discovery
biomarkers.
Furthermore,
potential
diagnosis,
prognosis,
treatment
diseases
over
decade
reviewed.
present
review
aims
inspire
readers
explore
new
avenues
biomarker
research
development.
Language: Английский
Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based Detection
Shibam Das,
No information about this author
Ankit Awasthi,
No information about this author
Ravindra K. Rawal
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 6, 2025
Abstract
Biomarkers
have
become
crucial
tools
in
the
diagnosis,
prognosis,
and
therapeutic
monitoring
of
various
diseases.
This
review
focuses
on
classification
biomarkers
based
three
core
categories:
(i)
their
characteristics,
(ii)
clinical
applications,
(iii)
relevance
genetic
molecular
biology.
The
importance
across
diseases
is
emphasized,
along
with
recent
advancements
detection.
A
comprehensive
discussion
biomarker
development
pipeline,
particularly
mass
spectrometry
(MS)-based
discovery,
validation,
verification,
presented.
article
also
delves
into
MS-based
techniques
used
for
detection
disease
such
as
Alzheimer’s,
hepatocellular
carcinoma,
ovarian
cancer,
tuberculosis,
well
highlighting
research.
Finally,
explores
future
perspectives
discovery
detection,
focusing
evolving
role
MS
advancing
science
its
application
research
settings.
Language: Английский
Elevated Levels of Serum Biomarkers Associated with Damage to the CNS Neurons and Endothelial Cells Are Linked with Changes in Brain Connectivity in Breast Cancer Patients with Vestibulo-Atactic Syndrome
Pathophysiology,
Journal Year:
2023,
Volume and Issue:
30(2), P. 260 - 274
Published: June 15, 2023
Vestibulo-atactic
syndrome
(VAS),
which
represents
a
combination
of
motor
and
vestibular
disorders,
can
be
manifested
as
clinical
complication
breast
cancer
treatment
has
significant
impact
on
patients'
quality
life.
The
identification
novel
potential
biomarkers
that
might
help
to
predict
the
onset
VAS
its
progression
could
improve
management
this
group
patients.
In
current
study,
levels
intercellular
cell
adhesion
molecule
1
(ICAM-1),
platelet/endothelial
(PECAM-1),
NSE
(neuron-specific
enolase),
antibodies
recognizing
NR-2
subunit
NMDA
receptor
(NR-2-ab)
were
measured
in
blood
serum
BC
survivor
patients
with
vestibulo-atactic
(VAS)
associated
brain
connectome
data
obtained
via
functional
magnetic
resonance
imaging
(fMRI)
studies.
A
total
21
registered
open,
single-center
trial
compared
age-matched
healthy
female
volunteers
(control
group)
(n
=
17).
demonstrated
higher
ICAM-1,
PECAM-1,
lower
value
NR-2-ab,
values
654.7
±
184.8,
115.3
37.03,
49.9
103.9,
0.5
0.3
pg/mL,
respectively,
volunteers,
230.2
44.8,
62.8
15.6,
15.5
6.4,
1.4
0.7
pg/mL.
According
fMRI
(employing
seed-to-voxel
ROI-to-ROI
methods),
VAS,
changes
detected
connectivity
areas
involved
regulation
postural-tonic
reflexes,
coordination
movements,
balance.
conclusion,
elevated
may
reveal
damage
CNS
neurons
endothelial
cells
is,
turn,
change
Language: Английский
Nervous system damage in breast cancer patients receiving chemotherapy
Journal of Volgograd State Medical University,
Journal Year:
2024,
Volume and Issue:
20(4), P. 22 - 27
Published: Jan. 27, 2024
This
article
presents
modern
ideas
about
the
problem
of
damage
to
nervous
system
in
patients
with
breast
cancer
receiving
chemotherapy.
Breast
is
most
common
women
worldwide.
To
date,
chemotherapy
increasingly
used
treatment
regimens.
However,
many
chemotherapeutic
drugs
are
potentially
neurotoxic,
which
increases
risks
acute
and
delayed
side
effects,
including
both
central
peripheral
systems
form
cognitive
impairment
post-chemotherapeutic
polyneuropathy,
significantly
worsen
quality
life
patients.
Due
increased
survival
rate
patients,
knowledge
potential
neurotoxic
effect
timely
diagnosis
particular
relevance.
Language: Английский
Predictive role of neuron-specific enolase and S100-β in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke
Open Medicine,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Jan. 1, 2024
We
aimed
to
assess
whether
neuron-specific
enolase
(NSE)
and
S100-β
levels
are
associated
with
early
neurological
deterioration
(END)
in
patients
acute
ischemic
stroke
(AIS).
Language: Английский
Сerebrovascular disorders in patients with postmastectomy syndrome
Russian Journal for Personalized Medicine,
Journal Year:
2023,
Volume and Issue:
3(1), P. 54 - 63
Published: March 23, 2023
The
article
is
devoted
to
one
of
the
manifestations
post-mastectomy
syndrome
-
cerebrovascular
disorders
that
develop
in
patients
after
radical
treatment
breast
cancer.
literature
review
considers
pathogenetic
aspects
disorders,
clinical
manifestations,
methods
diagnosis
and
this
pathology.
Language: Английский
Clinical and neuroimaging laboratory possibilities of diagnostics of vestibulo-atactic syndrome in patients with postmastectomic syndrome
Translational Medicine,
Journal Year:
2023,
Volume and Issue:
10(1), P. 25 - 35
Published: April 7, 2023
Background.
In
recent
years,
the
prognosis
of
survival
after
treatment
for
breast
cancer
(BC)
has
improved
significantly,
leading
to
an
increase
in
life
expectancy
patients
and
incidence
long-term
side
effects
therapy.
reducing
risks
complications
developing
a
unified
algorithm
diagnosing
cerebral
are
necessary
improve
quality
patients.
Objective
.
To
correlate
CNS
endothelium
damage
biomarkers
concentration
functional
connectivity
brain
with
newly
diagnosed
vestibulo-atactic
syndrome
(VAS)
without
it
late
period
radical
cancer.
Design
methods
The
study
involved
21
VAS
postoperative
cancer,
as
well
group
healthy
volunteers
—
17
people.
Biomarkers
were
determined
by
ELISA.
Functional
MRI
was
performed.
Results
An
markers
endothelial
(ICAM,
PECAM)
noted
post-mastectomy
(PMES)
VAS,
compare
control
PMES
group.
processes
disorganization
formation
strengthening
interand
intrahemispheric
connections
using
fMRI.
Conclusion.
development
novel
diagnostics
methods,
including
use
fMRI
determination
different
promising
improvement
effectiveness
PMES.
Language: Английский